Customizing biomimetic surface attributes of dendritic lipopeptide nanoplatforms for extended circulation

Copyright © 2023 Elsevier Inc. All rights reserved..

The pressing demand for innovative approaches to create delivery systems with heightened drug loading and prolonged circulation has spurred numerous efforts, yielding some successes but accompanied by constraints. Our study proposes employing dendritic lipopeptide with precisely balanced opposing charges to extend blood residency for biomimetic nanoplatforms. Neutrally mixed-charged zwitterionic nanoparticles (NNPs) achieved a notable 19 % simvastatin loading content and kept stable even after one-month storage at 4 °C. These nanoplatforms demonstrated low cytotoxicity in NIH-3T3 and L02 cells and negligible hemolysis (<5 %). NNPs inhibited protein adhesion (>95 %) from positively and negatively charged sources through surface hydration. In comparison to positively charged CNPs, NNPs demonstrated an 86 % decrease in phagocytic rate by BMDMs, highlighting their efficacy. Importantly, NNPs showed prolonged circulation compared to CNPs and free simvastatin. These findings highlight the potential of this biomimetic nanoplatform for future therapeutic applications with enhanced drug loading and circulation traits.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:56

Enthalten in:

Nanomedicine : nanotechnology, biology, and medicine - 56(2024) vom: 15. Feb., Seite 102726

Sprache:

Englisch

Beteiligte Personen:

Wei, Jingjing [VerfasserIn]
Zhou, Yin [VerfasserIn]
He, Yiyan [VerfasserIn]
Zhao, Wentao [VerfasserIn]
Luo, Zhiqiang [VerfasserIn]
Yang, Jian [VerfasserIn]
Mao, Hongli [VerfasserIn]
Gu, Zhongwei [VerfasserIn]

Links:

Volltext

Themen:

AGG2FN16EV
Biomimetic surface
Dendritic lipopeptide
Journal Article
Long circulation
Pharmaceutical Preparations
Simvastatin
Systemic delivery
Zwitterionic

Anmerkungen:

Date Completed 06.02.2024

Date Revised 06.02.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.nano.2023.102726

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM365432938